
Mimosa De
Examiner (ID: 17726)
| Most Active Art Unit | 2913 |
| Art Unit(s) | 2913, 5332, 2900, 2931 |
| Total Applications | 6546 |
| Issued Applications | 6484 |
| Pending Applications | 21 |
| Abandoned Applications | 45 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17859822
[patent_doc_number] => 11440968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)
[patent_app_type] => utility
[patent_app_number] => 16/317972
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8680
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317972 | Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) | Jul 16, 2017 | Issued |
Array
(
[id] => 17281713
[patent_doc_number] => 11198734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Anti-Axl antagonistic antibodies
[patent_app_type] => utility
[patent_app_number] => 16/098933
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 35388
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098933 | Anti-Axl antagonistic antibodies | Jun 20, 2017 | Issued |
Array
(
[id] => 15035793
[patent_doc_number] => 20190328901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
[patent_app_type] => utility
[patent_app_number] => 16/310738
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -134
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310738
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310738 | COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS | Jun 18, 2017 | Abandoned |
Array
(
[id] => 15035705
[patent_doc_number] => 20190328857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => CALR AND JAK2 VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/308164
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308164 | CALR AND JAK2 VACCINE COMPOSITIONS | Jun 8, 2017 | Abandoned |
Array
(
[id] => 15342471
[patent_doc_number] => 20200009127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => USE OF MTOR INHIBITOR AND CHLOROQUINE FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/490892
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490892 | Use of mTOR inhibitor and chloroquine for treating cancer | Mar 7, 2017 | Issued |
Array
(
[id] => 16326900
[patent_doc_number] => 20200297865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => CONJUGATES COMPRISING SELF-IMMOLATIVE GROUPS AND METHODS RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 15/779446
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779446
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779446 | Conjugates comprising self-immolative groups and methods related thereto | Nov 22, 2016 | Issued |
Array
(
[id] => 19472626
[patent_doc_number] => 12102689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Anti-CD22 antibody-maytansine conjugates and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/774384
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 31
[patent_no_of_words] => 46673
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774384 | Anti-CD22 antibody-maytansine conjugates and methods of use thereof | Nov 7, 2016 | Issued |
Array
(
[id] => 9518956
[patent_doc_number] => 20140155448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'AMINO-ACID-CONTAINING COMPOSITION FOR ENHANCING RECOVERY FROM MUSCLE FATIGUE'
[patent_app_type] => utility
[patent_app_number] => 14/175154
[patent_app_country] => US
[patent_app_date] => 2014-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4712
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14175154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/175154 | Amino-acid-containing composition for enhancing recovery from muscle fatigue | Feb 6, 2014 | Issued |